Amgen (AMGN)
$306.38
0.00 (0.00%)
AMGN Stock Quote Delayed 30 Minutes
Will This FDA Approval Affect Amgen Stock Significantly?
AMGN stock is still riding on a rocky road despite news of a new FDA approval. Here's what Amgen investors need to know.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
294
Day's Range
-
52-Week Range
$253.30 - $346.85
Dividend & Yield
$9.00 (2.94%)
AMGN Stock Predictions, Articles, and Amgen News
These 9 Dividend Stocks Are About to Soar — Thanks to Donald Trump
There’s a lot uncertainty in today’s market, but one thing is guaranteed ... The new tax reform law is about to cause an avalanche of money to rush into dividend stocks in the weeks and months ahead.
5 Companies Making Giant Buybacks
Buybacks are quickly becoming a hot topic on Wall Street, and with buyback activity surging, it's important to find the best companies that are doing them the right way.
5 Cheap Large Cap Stocks to Buy Now
The tide has turned and the large caps are now under performing. Value investors should take a look. Compare Brokers....
5 Top-Ranked High-Beta Stocks to Play the Roaring Market
Wall Street at a three-month high. Bet on these five high-beta top-ranked stocks. Compare Brokers....
Trade of the Day: Amgen, Inc. Clears a Breakout Hurdle
Large-cap biotech stocks as a group rallied along with the broader stock market on Wednesday. While so doing, some big names like AMGN stock broke past key near-term technical resistance.
Biotech ETFs Are the Best Way to Play the Recovering Sector
The biotech sector peaked in 2015. While it bounced back from lows, biotech ETFs give investors exposure to the sector as it recovers.
Amgen, Inc. (AMGN) Beats Q1 Estimates, Posts Weak F18 Guidance
Amgen (AMGN) had a mixed quarterly earnings report as the company topped analysts' earnings expectations, but its full-year outlook missed the mark.
7 Retirement Stocks for the Coming Correction
Defensive stocks are tough to find nowadays, but these seven retirement stocks offer long-term potential and some downside protection as well.
5 Cash-Rich Dividend Stocks to Buy
When it comes to dividend stocks, cash is king. These five stocks have huge cash balances and cash flows to keep the payouts coming.
The Amgen, Inc. Stock Spring Is About to Pop
Amgen stock is coiling like a spring. When the breakout comes, use AMGN call spreads to profit.
Sell for Amgen (AMGN) This Week
Amgen (AMGN) remains a Sell this week based on the latest market intelligence, and comparative pricing of its shares.
Wednesday’s Vital Data: Alibaba Group Holding Ltd (BABA), Amgen Inc. (AMGN) and Advanced Micro Devices, Inc. (AMD)
Alibaba (BABA) options jump on Baozun earnings, Amgen (AMGN) volume spikes ahead of FDA review and Advanced Micro (AMD) puts continue to pile up.
Sell for Amgen (AMGN) This Week
The Sell for Amgen (AMGN) this week is based on the most current comparative pricing of its shares and stock market rankings.
Sell for Amgen (AMGN) This Week
The Sell for Amgen (AMGN) this week is based on the most current relative pricing of its shares and stock market ratings.
At $182.68, Amgen (AMGN) a Sell
Amgen (AMGN) a Sell this week based on the most current stock market ratings, and comparative pricing of its shares.
This week, Amgen (AMGN) a Sell
At $183.57, Amgen (AMGN) a Sell based on the most recent comparative pricing of its shares and market intelligence.
Trade of the Day: Amgen, Inc. Remains a Promising Biotechnology Play
AMGN stock remains in a technically sound position and offers investors and traders well-defined risk, particularly after the two-week sell-off.
